Clinical Trials Directory

Trials / Unknown

UnknownNCT00152711

Impact of nCPAP Treatment on Liver Function in Patients With Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis

Impact of nCPAP Treatment on Liver Function in Patients With Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis: A Prospective Cross Over Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (planned)
Sponsor
University Hospital, Angers · Other Government
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate the impact of nasal continuous positive airway pressure (nCPAP) treatment on liver enzymes in patients with sleep apnea syndrome and nonalcoholic steatohepatitis. Using a cross over design, the evolution of liver enzymes will be evaluated in 40 patients during a consecutive period of 6 weeks, with and without nCPAP treatment.

Conditions

Interventions

TypeNameDescription
DEVICEnCPAP

Timeline

Start date
2004-09-01
First posted
2005-09-09
Last updated
2007-02-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00152711. Inclusion in this directory is not an endorsement.

Impact of nCPAP Treatment on Liver Function in Patients With Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis (NCT00152711) · Clinical Trials Directory